- Home
- SMTI vs RCEL Comparison
SMTI vs RCEL Comparison
Compare SMTI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- RCEL
- Stock Information
- Founded
- SMTI 1982
- RCEL N/A
- Country
- SMTI United States
- RCEL United States
- Employees
- SMTI N/A
- RCEL N/A
- Industry
- SMTI Medical/Dental Instruments
- RCEL Medical/Dental Instruments
- Sector
- SMTI Health Care
- RCEL Health Care
- Exchange
- SMTI Nasdaq
- RCEL Nasdaq
- Market Cap
- SMTI 252.1M
- RCEL 161.5M
- IPO Year
- SMTI N/A
- RCEL N/A
- Fundamental
- Price
- SMTI $29.84
- RCEL $5.71
- Analyst Decision
- SMTI Strong Buy
- RCEL Strong Buy
- Analyst Count
- SMTI 2
- RCEL 4
- Target Price
- SMTI $49.50
- RCEL $16.50
- AVG Volume (30 Days)
- SMTI 51.0K
- RCEL 308.7K
- Earning Date
- SMTI 08-11-2025
- RCEL 08-07-2025
- Dividend Yield
- SMTI N/A
- RCEL N/A
- EPS Growth
- SMTI N/A
- RCEL N/A
- EPS
- SMTI N/A
- RCEL N/A
- Revenue
- SMTI $91,569,883.00
- RCEL $71,661,000.00
- Revenue This Year
- SMTI $23.53
- RCEL $57.16
- Revenue Next Year
- SMTI $5.93
- RCEL $36.69
- P/E Ratio
- SMTI N/A
- RCEL N/A
- Revenue Growth
- SMTI 34.65
- RCEL 41.35
- 52 Week Low
- SMTI $25.86
- RCEL $4.71
- 52 Week High
- SMTI $39.08
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- SMTI 53.37
- RCEL 49.89
- Support Level
- SMTI $29.80
- RCEL $5.13
- Resistance Level
- SMTI $30.94
- RCEL $5.87
- Average True Range (ATR)
- SMTI 1.07
- RCEL 0.31
- MACD
- SMTI 0.29
- RCEL 0.14
- Stochastic Oscillator
- SMTI 73.17
- RCEL 83.19
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.